We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > original drugs

News List

First Generic Drugs Approved in China in 2022 Zhulikou/PharmaSources
February 15, 2023
List of the First Generic Drugs Approved in China in 2022
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? (2) Y-lp.com
January 26, 2018
The blood lipid regulating drugs are second only to the antineoplastic chemical drugs both on the Chinese and global markets. Statins account for about 90% share on the blood lipid regulating prescription drug market in China.
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? Y-lp.com
January 25, 2018
The imatinib mesylate is originally developed by Novartis, and indicated for chronic myelogenous leukemia and malignant gastrointestinal stromal tumors.
Achievements of 5 Transnational Pharmaceutical Enterprises in China! en-CPhI.cn
August 28, 2017
Greeting Key Nodes in the Transition in China, High-speed Growth being a Normal